These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 25523732

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
    Stege EM, Kros JM, de Bruin HG, Enting RH, van Heuvel I, Looijenga LH, van der Rijt CD, Smitt PA, van den Bent MJ.
    Cancer; 2005 Feb 15; 103(4):802-9. PubMed ID: 15637687
    [Abstract] [Full Text] [Related]

  • 23. How to use molecular markers when caring for a patient with brain cancer: 1P/19Q as a predictive and prognostic marker in the neuro-oncology clinic.
    van den Bent MJ.
    Am Soc Clin Oncol Educ Book; 2013 Feb 15; ():114-6. PubMed ID: 23714473
    [Abstract] [Full Text] [Related]

  • 24. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.
    Gorlia T, Delattre JY, Brandes AA, Kros JM, Taphoorn MJ, Kouwenhoven MC, Bernsen HJ, Frénay M, Tijssen CC, Lacombe D, van den Bent MJ.
    Eur J Cancer; 2013 Nov 15; 49(16):3477-85. PubMed ID: 23896377
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms.
    Singh VY, Chacko G, Chacko AG, Rajshekhar V.
    Neurol India; 2014 Nov 15; 62(1):32-6. PubMed ID: 24608451
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Anaplastic glioma. Neuropathology, molecular diagnostics and current study concepts].
    Wick W, Weller M.
    Nervenarzt; 2010 Aug 15; 81(8):928-30, 932-5. PubMed ID: 20635074
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Favorable long-term outcome of low-grade oligodendrogliomas irrespective of 1p/19q status when treated without radiotherapy.
    Iwadate Y, Matsutani T, Hasegawa Y, Shinozaki N, Higuchi Y, Saeki N.
    J Neurooncol; 2011 May 15; 102(3):443-9. PubMed ID: 20721680
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Association of 1p/19q Codeletion and Radiation Necrosis in Adult Cranial Gliomas After Proton or Photon Therapy.
    Acharya S, Robinson CG, Michalski JM, Mullen D, DeWees TA, Campian JL, Chundury A, Bottani B, Hallahan DE, Bradley JD, Huang J.
    Int J Radiat Oncol Biol Phys; 2018 Jun 01; 101(2):334-343. PubMed ID: 29534896
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.
    McDonald JM, See SJ, Tremont IW, Colman H, Gilbert MR, Groves M, Burger PC, Louis DN, Giannini C, Fuller G, Passe S, Blair H, Jenkins RB, Yang H, Ledoux A, Aaron J, Tipnis U, Zhang W, Hess K, Aldape K.
    Cancer; 2005 Oct 01; 104(7):1468-77. PubMed ID: 16088966
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.
    Thomas AA, Abrey LE, Terziev R, Raizer J, Martinez NL, Forsyth P, Paleologos N, Matasar M, Sauter CS, Moskowitz C, Nimer SD, DeAngelis LM, Kaley T, Grimm S, Louis DN, Cairncross JG, Panageas KS, Briggs S, Faivre G, Mohile NA, Mehta J, Jonsson P, Chakravarty D, Gao J, Schultz N, Brennan CW, Huse JT, Omuro A.
    Neuro Oncol; 2017 Oct 01; 19(10):1380-1390. PubMed ID: 28472509
    [Abstract] [Full Text] [Related]

  • 40. Clinicohistological study of oligodendroglioma and oligoastrocytoma.
    Tamura M, Zama A, Kurihara H, Kano T, Imai H, Ishiuchi S, Iwai T, Naito I.
    Brain Tumor Pathol; 1997 Oct 01; 14(1):35-9. PubMed ID: 9384800
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.